Personalized survival models for choosing irradiated tumor burden on combined radiotherapy and immune checkpoint inhibitors in stage IV NSCLC patients
{{output}}
Purpose: To assess the effects of irradiated tumor burden (ITB) and key prognostic factors for patients with advanced non-small cell lung cancer (NSCLC) who received a combination treatment of radiotherapy (RT) and immune checkpo... ...
